There is limited clinical experience with NURTEC ODT overdosage. No specific antidote for the treatment of rimegepant overdose is available.
No overdose symptoms have been reported.
Treatment of an overdose of NURTEC ODT should consist of general supportive measures including monitoring of vital signs and observation of the clinical status of the patient. Rimegepant is unlikely to be significantly removed by dialysis because of high serum protein binding.
For management of a suspected drug overdose, contact your regional poison control centre.
There is limited clinical experience with NURTEC ODT overdosage. No specific antidote for the treatment of rimegepant overdose is available.
No overdose symptoms have been reported.
Treatment of an overdose of NURTEC ODT should consist of general supportive measures including monitoring of vital signs and observation of the clinical status of the patient. Rimegepant is unlikely to be significantly removed by dialysis because of high serum protein binding.
For management of a suspected drug overdose, contact your regional poison control centre.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.
To report an adverse event related to COMIRNATY, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.